Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $11.99 Analyst target: $19.75 Upside: 64.72%
AngioDynamics, Inc. designs, manufactures and sells various medical, surgical and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company is headquartered in Latham, New York.
See the full interactive analysis & chart →Informational only — not investment advice.